Skip to main content
HR 5127 114th Congress House

Curb Opioid Misuse By Advancing Technology Act of 2016

Official title: To amend the Federal Food, Drug, and Cosmetic Act to extend the exclusivity period for certain drug products developed or labeled so as to reduce drug abuse, and for other purposes.

Introduced: September 8, 2016 Introduced by: Griffith, H. Morgan Republican · Virginia See on congress.gov
Health Drug safety, medical device, and laboratory regulationDrug therapyDrug trafficking and controlled substancesDrug, alcohol, tobacco useMedical research
Sign in to write a letter Sign in to watch
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 6, 2016
Referred to the Subcommittee on Health.
Apr 29, 2016
Introduced in House
Apr 29, 2016
Referred to the House Committee on Energy and Commerce.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 6, 2016

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Curb Opioid Misuse By Advancing Technology Act of 2016

This bill amends the Federal Food, Drug, and Cosmetic Act to extend the marketing exclusivity period for certain brand name drugs that the Food and Drug Administration approves: (1) on the basis of new clinical abuse potential studies, and (2) with labeling that characterizes the drug's abuse-deterrent properties. This extension does not apply to the marketing exclusivity period for new chemical entities.

The bill also extends the marketing exclusivity period for generics of these drugs.
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 5
All 5 Democratic 3 Republican 2
R
Blackburn, Marsha
Tennessee · Nov 14, 2016
 D
Wilson, Frederica S.
Florida · Nov 14, 2016
 D
Veasey, Marc A.
Texas · Sep 8, 2016
 D
Boyle, Brendan F.
Pennsylvania · Jun 28, 2016
 R
Bilirakis, Gus M.
Florida · Apr 29, 2016
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5127: Curb Opioid Misuse By Advancing Technology Act of 2016. 114th Congress. Open America. https://openamerica.io/bill/114-HR-5127/
MLA
"H.R. 5127: Curb Opioid Misuse By Advancing Technology Act of 2016." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-5127/.
Bluebook (legal)
H.R. 5127, 114th Cong. (2026), https://openamerica.io/bill/114-HR-5127/.
Markdown link
[H.R. 5127: Curb Opioid Misuse By Advancing Technology Act of 2016](https://openamerica.io/bill/114-HR-5127/)
Report a problem